Back to today’s briefing

Story perspectives

Revolutionary Test Promises Smarter Thyroid Cancer Treatments

5/15/2025

50 8

Summary

Story summary

Oliver Bathe, a University of Calgary professor, urges a transformative approach to treating papillary thyroid cancer (PTC). With the innovative Thyroid GuidePx® test, patients can now receive precise assessments of their recurrence risk, paving the way for smarter surgical choices. This breakthrough seeks to minimize overtreatment and enhance patient outcomes amid the alarming rise in thyroid cancer cases.

1 of 1

Story summary

Oliver Bathe, a University of Calgary professor, urges a transformative approach to treating papillary thyroid cancer (PTC). With the innovative Thyroid GuidePx® test, patients can now receive precise assessments of their recurrence risk, paving the way for smarter surgical choices. This breakthrough seeks to minimize overtreatment and enhance patient outcomes amid the alarming rise in thyroid cancer cases.